Monoclonal antibodies against the human metalloprotease EC 3.4.24.15 label neurofibrillary tangles in Alzheimer's disease brain

Journal of Neurochemistry

Volumn 66, Issue 5, 1996, Pages 2011-2018

  Conn, Kelly J ^a   Pietropaolo, Michael ^a   Ju, Shyr Te ^a   Abraham, Carmela R ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Amyloid precursor protein; EC 3.4.24.15; Neurofibrillary tangles; Protease; Tau

Indexed keywords

AMYLOID BETA PROTEIN; METALLOPROTEINASE; PROTEINASE;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BRAIN REGION; ENZYME ACTIVITY; MONKEY; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

EID: 0029933172     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1996.66052011.x     Document Type: Article

References (46)

1. Abraham C. R., Selkoe D. J., and Potter H. (1988) Immunochemical identification of the serine protease inhibitor α1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501.
2. Abraham C. R., Driscoll J., Potter H., Van Nostrand W. E., and Tempst P. (1991) A calcium activated protease from Alzheimer's disease brain cleaves at the N-terminus of the amyloid β protein. Biochem. Biophys. Res. Commun. 174, 790-796.
3. Abraham C. R., Kanemaru K., and Mucke L. (1993) Expression of cathepsin G-like and antichymotrypsin-like proteins in reactive astrocytes. Brain Res. 621, 222-232.
4. Abraham C. R., Conn K. J., Pietropaolo M., Amaratunga A., Fine R. E., and Meckelein B. (1994) Localization of human metalloprotease capable of generating potentially amyloidogenic fragments from the amyloid protein. Soc. Neurosci. Abstr. 20, 293.
5. Ashall F. and Goate A. M. (1993) Role of the β-amyloid precursor protein in Alzheimer's disease. Trends Biochem. Sci. 19, 42-46.
6. Bashin R., Gregory L., Morozov I., and Goldgaber D. (1994) A processing pathway for amyloid β-protein precursor generates a secreted form with an intact carboxyl terminus. Amyloid: Int. J. Exp. Clin. Invest. 1, 221-231.
7. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β protein toxicity. Cell 77, 817-827.
8. Busciglio J., Gabuzda D., Matsudaira P., and Yankner B. (1993) Generation of β-amyloid in the secretory pathway in neuronal and non-neuronal cells. Proc. Natl. Acad. Sci USA 90, 2092-2096.
9. Busciglio J., Lorenzo A., and Yankner B. (1995) β Amyloid fibrils induce tau phosphorylation and loss of microtubule binding. Neuron 14, 879-888.
10. Conn K.-J., Papastoitsis G., Meckelein B., and Abraham C. R. (1994) Identification of full length β-amyloid precursor protein in human neuronal and non neuronal cell culture supernatant: a possible extracellular source for the generation of Aβ. Amyloid: Int. J. Exp. Clin. Invest. 1, 232-239.
11. Dando P. M., Brown M. A., and Barrett A. J. (1993) Human thimet oligopeptidase. Biochem. J. 294, 451-457.
12. Dovey H. F., Seubert P. A., Sinha S., McConlogue L., Little S. P., and Johnstone E. M. (1992) Patent WO 92/07068.
13. Dyrks T., Dyrks E., Hartmann T., Masters C. L., and Beyreuther K. (1992) Amyloidogenicity of βA4 and βA4-bearing amyloid precursor fragments by metal-catalyzed oxidation. J. Biol. Chem. 267, 18210-18217.
14. Eikelenboom P., Hack C. E., Rozemuller J. M., and Stam F. C. (1989) Complement activation in amyloid plaques in Alzheimer's dementia. Virchows Arch. [B] 56, 259-262.
15. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., and Ward P. J. (1990) Cleavage of amyloid beta protein during constitutive processing of its precursor. Science 248, 1122-1124.
16. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., and Selkoe D. J. (1992) Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359, 322-325.
17. Healy D. P. and Orlowski M. (1992) Immunocytochemical localization of endopeptidase 24.15 in rat brain. Brain Res. 571, 121-128.
18. Hershko A. (1988) Ubiquitin-mediated protein degradation. J. Biol. Chem. 263, 15237-15240.
19. Khachaturian Z. S. (1985) Diagnosis of Alzheimer's disease. Arch. Neurol. 42, 1097-1105.
20. Laemmli U. K (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227, 680-685.
21. Lee V. M.-Y. and Trojanowski J. Q. (1992) The disordered neuronal cytoskeleton in Alzheimer's disease. Curr. Opin. Neurobiol. 2, 653-656.
22. Lee V. M.-Y., Balin B. J., Otvos L., and Trojanowski J. Q. (1991) A68. A major subunit of paired helical filaments and derivatized forms of normal tau. Science 251, 675-678.
23. Lorenzo A. and Yankner B. A. (1994) β-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proc. Natl. Acad. Sci. USA 91, 12243-12247.
24. Mann D. M. A. and Esiri M M. (1989) The pattern of acquisition of plaques and tangles in the brains of patients under 50 years of age with Down's syndrome. J. Neurol. Sci. 89, 169-179.
25. Mori H., Kondo J., and Ihara Y. (1987) Ubiquitin is a component of paired helical filaments in Alzheimer's disease. Science 235, 1641-1644.
26. Mon H., Takio K., Ogawara M., and Selkoe D. J. (1992) Mass spectometry of purified amyloid β protein in Alzheimer's disease. J. Biol Chem. 267, 17082-17086.
27. Namba Y., Tomonaga M., Kawasaki H., Otomo E., and Ikeda K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jacob disease. Brain Res. 541, 163-166.
28. Papastoitsis G., Siman R., Scott R., and Abraham C. R. (1994) Identification of a metalloprotease from Alzheimer's disease brain able to degrade the β-amyloid precursor protein and generate amyloidogenic fragments. Biochemistry 33, 192-199.
29. Perry G., Friedman R., Shaw G., and Chau V. (1987) Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites in Alzheimer's disease brains. Proc. Natl. Acad. Sci. USA 84, 3033-3036.
30. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., and Cotman C. W. (1993) Neurodegeneration induced by β-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 13, 1676-1687.
31. Podlisny M. B., Tolan D., and Selkoe D. J. (1991) Homology of the amyloid β-protein precursor in monkey and human supports a primate model for β-amyloidosis in Alzheimer's disease. Am. J. Pathol. 138, 1423-1435.
32. Razzaboni B. L., Papastoitsis G., Koo E. H., and Abraham C. R. (1992) A calcium stimulated serine protease from monkey brain degrades the β-amyloid precursor protein. Brain Res. 589, 207-216.
33. Ripellino J. A., Vassilacopoulou D., and Robakis N. K. (1994) Solubilization of full-length amyloid precursor proteins from PC12 cell membranes. J. Neurosci. Res. 39, 211-218.
34. Selkoe D. J. (1994) Cell biology of the amyloid β-precursor and the mechanism of Alzheimer's disease. Annu. Rev. Cell Biol. 10, 373-403.
35. Selkoe D. J., Abraham C. R., Podlisny M. B., and Duffy L. K. (1986) Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease. J. Neurochem. 46, 1820-1834.
36. Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., McCormack R., Wolfert R., Selkoe D. J., Lieberburg I., and Schenk D. B. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325-327.
37. Seubert P., Oltersdorf T., Lee M. G., Barbour R., Blomquist C., Davis D. L., Bryant K., Fritz L. C., Galasko D., Thal L. J., Lieberburg I., and Schenk D. B. (1993) Secretion of beta-amyloid precursor protein cleaved at the amino terminus of the beta-amyloid peptide. Nature 361, 260-263.
38. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. B., Tintner R., Frangione B., and Younkin S. G. (1992) Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258, 126-129.
39. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., and Price D. L. (1990) Evidence that amyloid protein in Alzheimer's disease is not derived by normal processing. Science 248, 492-495.
40. Snow A. D., Mar H., Nochlin D., Kimata K., Kato M., Suzuki S., Hassell J., and Wright T. N. (1988) The presence of heparin sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease. Am. J. Pathol. 133, 456-463.
41. Sonnenberg-Reines J. L., Brown A. B., Tummolo M. A., Spruyt M. A., and Jacobsen J. S. (1994) Comparison of a brain purified metalloprotease with human cathepsin G and D: evaluation of sequence specificity using peptide substrates and regional selectivity using purified brain APP. Soc. Neurosci. Abstr. 20, 293.
42. Strittmatter W. J., Saunders A. M., Schmechel D., Pericak-Vance M., Enghild J., Salvesen G. S., and Roses A. D. (1993a) Apolipoprotein E: high avidity binding to β-amyloid and increased frequency of type 4 allele in late onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 1977-1981.
43. Strittmatter W. J., Weisgraber K. H., Huang D., Dong L.-M., Salvesen G. S., Pericak-Vance M., Schmechel D., Saunders A. M., Goldgaber D., and Roses A. D. (1993b) Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform specific effects and implications for late onset familial Alzheimer's disease. Proc. Natl. Acad. Sci. USA 90, 8098-8102.
44. Strittmatter W. J., Weisgraber K. H., Goedert M., Saunders A. M., Huang D., Corder E. H., Dong L.-M., Jakes R., Alberts M. J., Gilbert J. R., Han S.-H., Hulette C., Einstein E., Schmechel D. E., Pericak-Vance M. A., and Roses A. D. (1994) Microtubule instability and paired helical formation in the Alzheimer's disease brain as a function of apolipoprotein E genotype. Exp. Neurol. 125, 163-171.
45. Wisniewski T. and Frangione B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135, 235-238.
46. Yankner B. A., Dawes L. R., Fisher S., Villa-Komaroff S., Oster-Granite M., and Neve R. L. (1989) Neurotoxicity of a fragment of the amyloid precursor associated with Alzheimer's disease. Science 250, 279-282.